Stocksigma LogoStocksigma Logo

Infinium Pharmachem Receives In-Principle Approval for Migration to NSE Main Board

Infinium Pharmachem Limited has received in-principle approval from the National Stock Exchange of India on 18th Nov'26 for migrating its equity shares

Infinium Pharmachem Receives In-Principle Approval for Migration to NSE Main Board

Infinium Pharmachem Ltd 路 Others (Uncategorized) 路 18 Nov 2026, 11:46 pm

Infinium Pharmachem Receives In-Principle Approval for Migration to NSE Main Board Infinium Pharmachem Limited has received in-principle approval from the National Stock Exchange of India on 18th Nov'26 for migrating its equity shares from the NSE SME Platform (EMERGE) to the NSE Main Board. The approval covers 15,583,120 equity shares with a face value of Rs. 10 each. Final approval remains subject to the company submitting its listing application and equity listing agreement, with the in-principle approval valid for 45 days from issuance.

Original exchange filing (PDF)

More announcements from Infinium Pharmachem Ltd

All Infinium Pharmachem Ltd announcements